C, S., ET, B., K, S., M, J., JE, S., K, P., . . . PA, I. (2026). Corrigendum to "Histamine H1 receptor: A potential therapeutic target for pancreatic ductal adenocarcinoma". The Journal of pharmacology and experimental therapeutics, 393(4), 104305. https://doi.org/10.1016/j.jpet.2026.104305
Chicago Style (17th ed.) CitationC, Salmerón, et al. "Corrigendum to "Histamine H1 Receptor: A Potential Therapeutic Target for Pancreatic Ductal Adenocarcinoma"." The Journal of Pharmacology and Experimental Therapeutics 393, no. 4 (2026): 104305. https://doi.org/10.1016/j.jpet.2026.104305.
MLA (9th ed.) CitationC, Salmerón, et al. "Corrigendum to "Histamine H1 Receptor: A Potential Therapeutic Target for Pancreatic Ductal Adenocarcinoma"." The Journal of Pharmacology and Experimental Therapeutics, vol. 393, no. 4, 2026, p. 104305, https://doi.org/10.1016/j.jpet.2026.104305.